LKT Labs

Biochemicals for Life Science Research

Awaiting product image

Recombinant HIV-1 “0” group consensus

Product ID R2815
Cas No.
Purity ≥95%
Product Unit SizeCostQuantityStock
100 µg $636.80 In stock
1 mg $1,783.00 In stock
Bulk Quote

Quicklinks

Description

Recombinant HIV-1 “0” group consensus is a recombinant HIV-1 antigen peptide fragment used to develop immunoassays such as EIAs, ELISAs, and RIPAs to test for HIV antibodies.

Product Info

Purity

≥95%

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

R2815 MSDS PDF
Info Sheet

R2815 Info Sheet PDF

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • Z3463

    Ziprasidone

    5-HT1A agonist, D2, 5-HT1D antagonist.
    ≥98%
  • R2711

    Recombinant HCV-Core Antigens

    Recombinant HIV core protein antigen fragment.
    ≥95%
  • P1763

    Peptide YY, human

    Endogenous neuropeptide, involved in enteric movem...
    ≥98%
  • A1097

    Ac-YVAD-pNA

    Caspase 1 substrate.
    ≥95%
  • S0500

    SB-203580

    p38 MAPK inhibitor.
    ≥98%
  • A0902

    N-Acetyl-S-(N′-phenylhexylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, antioxidant; HDAC inhibito...
    ≥98%
  • G2872

    Growth Hormone Releasing Factor, mouse

    Endogenous peptide hormone, involved in growth hor...
    ≥95%
  • S8009

    Substance P (7-11)

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • P1202

    PD-325901

    MEK1/2 and Raf inhibitor.
    ≥98%
  • B3211

    (+)-Bicuculline

    NMDA potentiator, GABA-A antagonist.
    ≥98%
  • H1894

    Hexestrol

    Synthetic catechol; ER agonist, microtubule polyme...
    ≥98%
  • C0376

    Catharanthine base

    Alkaloid found in Catharanthus, precursor in synth...
    ≥98%
  • P0369

    Parecoxib Sodium

    NSAID; COX-2 inhibitor.
    ≥99%
  • V0145

    Valinomycin

    Peptide, neutral ionophore.
    ≥98%
  • O4658

    Olopatadine Hydrochloride

    Mast cell stabilizer; histamine H1/2/3 antagonist.
    ≥99%
  • N8760

    NVP-TAE684

    ALK, c-Fes, LRRK2 inhibitor.
    ≥98%
  • A0401

    Abacavir

    Nucleoside (guanosine) analog; RT, guanylyl cyclas...
    ≥98%
  • A5056

    Amorolfine Hydrochloride

    14α-demethylase inhibitor.
    ≥98.5%
  • M1622

    Mefenamic Acid

    NSAID; GABA-A potentiator, COX-1/2 inhibitor.
    ≥98%
  • C0263

    L-Carnitine Hydrochloride

    Endogenous quaternary ammonium, required for fatty...
    ≥98%